ArticlePharmaceutics2022

Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines.

Timur R Nizamov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.